Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium
Ifeanyichukwu C. Ogobuiro, Amber L. Collier, Khadeja Khan, Iago De Castro Silva, Deukwoo Kwon, Gregory C. Wilson, Patrick B. Schwartz, Alexander A. Parikh, Chet W. Hammill, Hong Joo Kim, David A. Kooby, Daniel E. Abbott, Shishir K. Maithel, Rebecca A. Snyder, Syed A. Ahmad, Nipun B. Merchant, Jashodeep Datta
Topics & Concepts
MedicineFOLFIRINOXGemcitabinePancreatic cancerInternal medicinePancreatectomyChemotherapyOncologyNeoadjuvant therapySurgical oncologyGastroenterologyRadiation therapyHazard ratioConfidence intervalProportional hazards modelCancerSurgeryPancreasBreast cancerOxaliplatinColorectal cancerPancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesPancreatitis Pathology and Treatment